Mice hypomorphic for Tom1l2 exhibited numerous infections and tumors compared to wild-type littermates. Associated with this increased risk for infection and tumor formation, apparently healthy Tom1l2 hypomorphs also had splenomegaly, elevated B- and T-cell counts, and an impaired humoral response, although at a reduced penetrance.
Furthermore, cellular localization studies showed that a Tom1l2-GFP fusion protein colocalizes with Golgi compartments, supporting the role of Tom1l2 in cellular trafficking, while molecular modeling and bioinformatic analysis of Tom1l2 illustrated a structural basis for a functional role in trafficking. These results indicate a role for Tom1l2 in the immune response and possibly in tumor suppression.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Target Of Myb1 Like Protein 2 (TOM1L2) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Target Of Myb1 Like Protein 2 (TOM1L2) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Target Of Myb1 Like Protein 2 (TOM1L2) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Target Of Myb1 Like Protein 2 (TOM1L2) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Target Of Myb1 Like Protein 2 (TOM1L2) | ELISA Kit Customized Service Offer |
Organism species: Mus musculus (Mouse)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Target Of Myb1 Like Protein 2 (TOM1L2) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Target Of Myb1 Like Protein 2 (TOM1L2) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Target Of Myb1 Like Protein 2 (TOM1L2) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Target Of Myb1 Like Protein 2 (TOM1L2) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Target Of Myb1 Like Protein 2 (TOM1L2) | ELISA Kit Customized Service Offer |
Organism species: Rattus norvegicus (Rat)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Target Of Myb1 Like Protein 2 (TOM1L2) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Target Of Myb1 Like Protein 2 (TOM1L2) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Target Of Myb1 Like Protein 2 (TOM1L2) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Target Of Myb1 Like Protein 2 (TOM1L2) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Target Of Myb1 Like Protein 2 (TOM1L2) | ELISA Kit Customized Service Offer |
- "Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse."Genome Res. 12:713-728(2002) [PubMed] [Europe PMC] [Abstract]
- "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
- "DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage." Nature 440:1045-1049(2006) [PubMed] [Europe PMC] [Abstract]
- "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
- "Recruitment of clathrin onto endosomes by the Tom1-Tollip complex."Biochem. Biophys. Res. Commun. 341:143-149(2006) [PubMed] [Europe PMC] [Abstract]
- "The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors."Mol. Cell. Biol. 26:1932-1947(2006) [PubMed] [Europe PMC] [Abstract]
- "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
- "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
- "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]